Research
The Center participates in several research programs
ranging from basic pharmacology through clinical trials. The strength of the Center lies
primarily in the translation of cutting edge technology into direct advances in patient
care.
The major initiative at the Center is the pharmacologic
modification of ocular tissues in glaucoma. This includes the development of new
technology for chronic telemetric intraocular pressure monitoring in glaucoma. This will
permit us to continuously monitor intraocular pressure in conscious, free roaming animals
to evaluate the effect of drug therapy. Later, this technology may be extended to patients
to improve patient care by permitting continuous monitoring of IOP on an out patient
basis.
This technology will also be applied to our studies of
cyclosporine-augmented trabeculectomy and trabeculoplasty and later to optic
neuroprotective effects of novel anti-ischemic drugs including free radical scavengers and
iron chelators. |
